PAA Share Price

Open 0.06 Change Price %
High 0.06 1 Day 0.00 0.00
Low 0.06 1 Week -0.01 -14.29
Close 0.06 1 Month -0.02 -25.00
Volume 493445 1 Year -0.02 -25.00
52 Week High 0.10
52 Week Low 0.05
PAA Important Levels
Resistance 2 0.06
Resistance 1 0.06
Pivot 0.06
Support 1 0.06
Support 2 0.06
ASX Australia Most Active Stocks
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
AGO 0.01 0.00%
AGO 0.01 0.00%
AGO 0.01 0.00%
TLS 4.36 0.93%
TLS 4.36 0.93%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
GCR 0.02 100.00%
GCR 0.02 100.00%
GBG 0.02 100.00%
GBG 0.02 100.00%
GBG 0.02 100.00%
PMQ 0.03 50.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
DAU 0.02 -33.33%
More..

Pharmaust Ltd (ASX: PAA)

PAA Technical Analysis 4
As on 28th Jun 2017 PAA Share Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.07 & Sell for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
PAA Target for June
1st Target up-side 0.1
2nd Target up-side 0.12
3rd Target up-side 0.13
1st Target down-side 0.06
2nd Target down-side 0.04
3rd Target down-side 0.03
PAA Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.pharmaust.com
PAA Address
PAA
29 The Avenue
Suite 7
Nedlands, WA 6009
Australia
Phone: 61 8 9386 4787
Fax: 61 8 9389 1464
PAA Latest News
Pharmaust says Epichem to deliver $3 mln in revenues for 2016/17   Reuters Key Development   - 30th May 17
PharmAust secures key China patent   NEWS.com.au   - 05th May 17
Compounding firm looks at NDA opportunity for reformulation of Mallinckrodt's ...   In-PharmaTechnologist.com   - 23rd Mar 17
PharmAust appoints Hopkins   Business News   - 02nd Mar 17
Pharmaust says Dr Richard Hopkins appointed ceo   Reuters Key Development   - 01st Mar 17
Juniper invests in tablet technology for UK site   In-PharmaTechnologist.com   - 22nd Jun 16
PharmAust signs mandate with Joseph Gunnar & co<PAA.AX>   Reuters Key Development   - 02nd Jun 16
The Aussie Company That's Curing Dogs with Cancer   Money Morning Australia   - 16th Jul 15
Pharmaust Limited's shares in pre-open   Proactive Investors Australia   - 12th Mar 15
Interactive Technical Analysis Chart Pharmaust Ltd ( PAA ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pharmaust Ltd
PAA Business Profile
PharmAust Limited, through its subsidiaries, provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries in Australia and internationally. The company operates through Corporate, Exploration, and Pharmaceutical segments. It offers a range of pharmaceutical impurities, degradants, and metabolites of active ingredients and excipients primarily for OTC and generic drugs. The company is also involved in the custom synthesis of analogue libraries, scaffolds, and intermediates; contract drug discovery activities; and development of therapeutic cancer products. In addition, it engages in the exploration of tenements for minerals, and oil and gas. The company holds 80% downstream interests in the Luke River project, a precious and base metal exploration project located in northeast Macedonia. PharmAust Limited is based in Nedlands, Australia.